nach oben

Erschienen in:

01.03.2018 | Original Article

Predictors for the detection of prostate cancer and clinically significant prostate cancer using TRUS-guided biopsy in patients with negative initial biopsy results

verfasst von: Sangjun Yoo, Juhyun Park, Sung Yong Cho, Min Chul Cho, Ja Hyeon Ku, Hwancheol Son, Cheol Kwak, Hyeon Hoe Kim, Hyeon Jeong

Erschienen in: World Journal of Urology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to determine the predictors for the detection of prostate cancer and clinically significant prostate cancer in the setting of repeat prostate biopsy using trans-rectal ultrasonography-guided biopsy.

Methods

A total of 636 patients who underwent repeat prostate biopsy were included. The patients were divided into two groups according to the repeat biopsy results (with vs. without prostate cancer). A multivariable analysis was performed to assess the predictors for the detection of prostate cancer and clinically significant prostate cancer.

Results

Prostate cancer was detected in 98 patients (15.4%). Although there was no difference in the prostate-specific antigen velocity, the prostate-specific antigen density was higher in the patients with prostate cancer at the initial (0.14 vs. 0.17 ng/mL/cc, p = 0.049) and repeat biopsies (0.17 vs. 0.26 ng/mL/cc, p < 0.001). The proportions of the patients who met the active surveillance criteria were as follows: 22.4% (Johns Hopkins), 30.6% (University of Toronto), 32.7% (University of California at San Francisco), 30.6% (Prostate Cancer Research International Active Surveillance), 27.6% (Memorial Sloan Kettering Cancer Center), and 13.3% (University of Miami). In the multivariable analysis, age, hypoechoic lesion on trans-rectal ultrasonography, and prostate-specific antigen density at the repeat biopsy were the significant predictors for prostate cancer and clinically significant prostate cancer.

Conclusions

Trans-rectal ultrasonography before repeat prostate biopsy and the prostate-specific antigen density are useful for selecting patients with a high probability for prostate cancer if repeat trans-rectal ultrasonography-guided biopsy is considered. In addition, these are also helpful for detecting clinically significant prostate cancer.

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618–629CrossRefPubMed

Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A (2009) Screening and prostate-cancer mortality in a randomized european study. N Engl J Med 360(13):1320–1328. https://doi.org/10.1056/NEJMoa0810084 CrossRefPubMed

Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJJ, Petros JA, Andriole GL (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324(17):1156–1161. https://doi.org/10.1056/nejm199104253241702 CrossRefPubMed

Ploussard G, Nicolaiew N, Marchand C, Terry S, Allory Y, Vacherot F, Abbou CC, Salomon L, Taille A (2013) Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial. BJU Int 111(6):988–996CrossRefPubMed

Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO (2010) Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 183(2):520–528CrossRefPubMed

Cheikh AB, Girouin N, Colombel M, Maréchal J-M, Gelet A, Bissery A, Rabilloud M, Lyonnet D, Rouvière O (2009) Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 19(3):770–778CrossRefPubMed

Pokorny MR, de Rooij M, Duncan E, Schröder FH, Parkinson R, Barentsz JO, Thompson LC (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66(1):22–29. https://doi.org/10.1016/j.eururo.2014.03.002 CrossRefPubMed

Altok M, Ward J, Chapin B, Pisters L, Pettaway C, Davis J (2017) PD43-09 cost analysis of different prostate biopsy modalities. J Urol 197(4):e821CrossRef

Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, Yamamoto T, Mamedov A, Loblaw A (2014) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33(3):272–277CrossRefPubMed

10.

Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, Van Der Schoot DK, Cornel EB, Conti GN (2013) Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 63(4):597–603CrossRefPubMed

11.

Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, Taneja SS, Thoeny H, Villeirs G, Villers A (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68(6):1045–1053CrossRefPubMed

12.

Loeb S, Sanda MG, Broyles DL, Shin SS, Bangma CH, Wei JT, Partin AW, Klee GG, Slawin KM, Marks LS (2015) The prostate health index selectively identifies clinically significant prostate cancer. J Urol 193(4):1163–1169CrossRefPubMed

13.

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, Committee G (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244–252PubMed

14.

Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, Walsh PC, Carter HB (2011) Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 29(16):2185–2190CrossRefPubMed

15.

Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A (2009) Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28(1):126–131CrossRefPubMed

16.

Dall’Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA (2008) Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112(12):2664–2670CrossRefPubMed

17.

Van Den Bergh RC, Vasarainen H, Van Der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, Van Der Hoeven J (2010) Short-term outcomes of the prospective multicentre ‘prostate cancer research international: active surveillance’ study. BJU Int 105(7):956–962CrossRefPubMed

18.

Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD (2008) Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 180(5):1964–1968CrossRefPubMedPubMedCentral

19.

Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M (2008) Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 101(2):165–169PubMed

20.

Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM (2012) Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 188(6):2152–2157CrossRefPubMedPubMedCentral

21.

Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS (2014) Value of targeted prostate biopsy using magnetic resonance–ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 65(4):809–815CrossRefPubMed

22.

Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P (2017) Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol 42(2):346–349CrossRef

23.

Borkowetz A, Platzek I, Toma M, Laniado M, Baretton G, Froehner M, Koch R, Wirth M, Zastrow S (2015) Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int 116(6):873–879. https://doi.org/10.1111/bju.13023 CrossRefPubMed

24.

Salami SS, Ben-Levi E, Yaskiv O, Ryniker L, Turkbey B, Kavoussi LR, Villani R, Rastinehad AR (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115(4):562–570. https://doi.org/10.1111/bju.12938 CrossRefPubMed

25.

Jeong IG, Dajani D, Verghese M, Hwang J, Cho YM, Hong JH, Kim C-S, Ahn H, Ro JY (2016) Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: a retrospective cohort study of radical prostatectomy. In: Urologic Oncology: Seminars and Original Investigations, 2016. Elsevier, vol 1, pp 3.e9–3.e14

26.

Takahashi H, Epstein JI, Wakui S, Yamamoto T, Furusato B, Zhang M (2014) Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan. The Prostate 74(3):321–325CrossRefPubMed

27.

Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA (2014) Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int 114(6b):e43–e49CrossRefPubMedPubMedCentral

28.

Radtke J, Boxler S, Kuru T, Wolf M, Alt C, Popeneciu I, Steinemann S, Huettenbrink C, Bergstraesser-Gasch C, Klein T (2015) Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance. Prostate Cancer Prostatic Dis 18(3):288–296CrossRefPubMed

29.

Benecchi L, Pieri AM, Melissari M, Potenzoni M, Pastizzaro CD (2008) A novel nomogram to predict the probability of prostate cancer on repeat biopsy. J Urol 180(1):146–149CrossRefPubMed

30.

Gosselaar C, Roobol MJ, Roemeling S, Wolters T, Van Leenders GJ, Schröder FH (2008) The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer. BJU Int 101(6):685–690CrossRefPubMed

Titel: Predictors for the detection of prostate cancer and clinically significant prostate cancer using TRUS-guided biopsy in patients with negative initial biopsy results
verfasst von: Sangjun Yoo
Juhyun Park
Sung Yong Cho
Min Chul Cho
Ja Hyeon Ku
Hwancheol Son
Cheol Kwak
Hyeon Hoe Kim
Hyeon Jeong
Publikationsdatum: 01.03.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 7/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2239-1

Neu im Fachgebiet Urologie

10.04.2024 | PSA-Screening | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Predictors for the detection of prostate cancer and clinically significant prostate cancer using TRUS-guided biopsy in patients with negative initial biopsy results

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Urologie

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Wie toxische Männlichkeit der Gesundheit von Männern schadet

TURP hat Vorteile im Vergleich mit der Embolisation

Langes Sitzen in der Freizeit korreliert mit erektiler Dysfunktion

Update Urologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2018

Transurethral resection of bladder cancer on the lateral bladder wall without obturator nerve block: extent of adductor spasms using the monopolar versus bipolar technique—a prospective randomised study

Penoscrotal versus minimally invasive infrapubic approach for inflatable penile prosthesis placement: a single-center matched-pair analysis

Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results

Reflections on personalized management of UTUC

Do longer or shorter cores yield more cancer?

The impact of time to metastasis on overall survival in patients with prostate cancer

Neu im Fachgebiet Urologie

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Wie toxische Männlichkeit der Gesundheit von Männern schadet

TURP hat Vorteile im Vergleich mit der Embolisation

Langes Sitzen in der Freizeit korreliert mit erektiler Dysfunktion

Update Urologie